Ocular Therapeutix, Inc. Virtual Annual Shareholder Meeting
Thursday, June 25, 2020 8:30 AM EDT
Ocular Therapeutix, Inc. at the Jefferies 2020 Healthcare Conference
Thursday, June 04, 2020 2:30 PM EDT
Q1 2020 Ocular Therapeutix, Inc. Earnings Conference Call
Friday, May 08, 2020 8:30 AM EDT

Corporate Profile

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Our product pipeline candidates utilize the hydrogel technology to provide differentiated drug delivery solutions that are designed to reduce the complexity and burden of current drop or injection regimens by creati
(Common Stock)

Data Provided by Refinitiv. Minimum 15 minutes delayed.